1. Allogeneic Stem Cell Transplantation for Relapsed or Refractory Lymphoma after Conditioning with BEAM/Fludarabine/TBI 
Alix O’Meara, Jörg Halter, Dominik Heim, Sabine Gerull, Christoph Bucher, Jakob Passweg, Andreas Buser, Martin Stern 
Biology of Blood and Marrow Transplantation 
Volume 19, Issue 1, Pages (January 2013)
DOI: /j.bbmt
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

2. Figure 1
Progression-free survival (PFS), treatment-related mortality (TRM), and relapse incidence of 50 patients with advanced lymphoma treated with allogeneic HSCT after conditioning with BEAM/fludarabine/TBI.
Biology of Blood and Marrow Transplantation  , 82-86DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions

3. Figure 2
Overall survival in patients stratified according to disease stage at transplant (CR, complete remission; PR, partial remission; P = .85) (A); by the donor type (P = .05) (B); and by disease histology (CLL, chronic lymphocytic leukemia; P = .69) (C).
Biology of Blood and Marrow Transplantation  , 82-86DOI: ( /j.bbmt )
Copyright © 2013 American Society for Blood and Marrow Transplantation Terms and Conditions